<http://webisa.webdatacommons.org/102481475>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/343098774>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/102481475> .
<http://webisa.webdatacommons.org/102481475>	<http://www.w3.org/ns/prov#value>	"low market acceptance as a result of lower demonstrated clinical safety or efficacy compared to other products or other potential disadvantages relative to alternative treatment methods; ??" .
<http://webisa.webdatacommons.org/102481475>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<getfilings.com> .